Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients
2012 · Breast Cancer Research and Treatment · 29 citations
https://doi.org/10.1007/s10549-011-1946-8